19 October 2017
News and Views
Links and Services
The most recent issue of Gut examines screening diabetic patients for NAFLD with controlled attenuation parameter and liver stiffness measurements.
Type 2 diabetes is an important risk factor for non-alcoholic fatty liver disease (NAFL
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors